Daniel Butler, MD
Internal Medicine · San Francisco, CANPI 1013320738
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Sanofi at 26.6% of the total. 2025 is the largest year on record at $239,707, more than ten times the $15 reported in 2020. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 248 payments — averaging $1399.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$92K
- Galderma Laboratories, L.p.$86K
- LEO Pharma Inc.$70K
- Regeneron Healthcare Solutions, Inc.$65K
- Boehringer Ingelheim$14K
- Novartis$8K
- plus $12K from 12 others
Across 124 payments — averaging $4415.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$309K
- Pfizer$201K
- Incyte Corporation$35K
- E.r. Squibb & Sons, L.L.C.$2K
What the payments were for
- Consulting fees$115,89233%
- Speaking & faculty fees$206,69860%
- Travel & lodging$17,5135%
- Food & beverage$6,9102%
- Education$1340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 54 | $92,244 |
| Galderma Laboratories, L.p. | 44 | $85,871 |
| LEO Pharma Inc. | 49 | $70,113 |
| Regeneron Healthcare Solutions, Inc. | 50 | $65,406 |
| Boehringer Ingelheim | 6 | $14,208 |
| Novartis | 7 | $7,532 |
| AbbVie | 14 | $6,017 |
| Sanofi US Services Inc. | 1 | $2,870 |
| Arcutis Biotherapeutics, Inc. | 7 | $2,052 |
| Pfizer | 3 | $210 |
| Lilly USA, LLC | 1 | $151 |
| Regeneron | 4 | $132 |
| Incyte Corporation | 3 | $126 |
| Johnson & Johnson | 1 | $80 |
| Intercept Pharmaceuticals, Inc. | 1 | $39 |
| Sun Pharmaceutical Industries Inc. | 1 | $33 |
| Amgen | 1 | $31 |
| Dermavant Sciences, Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$347,147 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $58,875 |
| Clobetasol Propionate | 34 | $1,058 |
| Fluorouracil | 17 | $1,023 |
| Triamcinolone Acetonide | 39 | $565 |
| Ketoconazole | 29 | $525 |
| Doxycycline Hyclate | 16 | $462 |
| Minoxidil | 17 | $256 |
| Hydrocortisone | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Francisco
- Fred CohenSan Francisco$929K
- John TeerlinkSan Francisco$819K
- Mark SmithSan Francisco$535K
- Lisa CapaldiniSan Francisco$434K
- Maria Dall'eraSan Francisco$417K
- Kenneth ColleySan Francisco$397K
- Louis CubbaSan Francisco$351K
- Laurence CorashSan Francisco$336K
- Felicia StermanSan Francisco$298K
- Riley BoveSan Francisco$283K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.